Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts.


Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
Historique:
received: 15 04 2019
revised: 19 05 2019
accepted: 28 05 2019
pubmed: 30 6 2019
medline: 15 9 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.

Identifiants

pubmed: 31253580
pii: S2213-2198(19)30547-1
doi: 10.1016/j.jaip.2019.05.051
pmc: PMC6733665
mid: NIHMS1045305
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Penicillins 0
Sulfonamides 0
beta-Lactams 0
Trimethoprim, Sulfamethoxazole Drug Combination 8064-90-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2151-2153

Subventions

Organisme : NIGMS NIH HHS
ID : P50 GM115305
Pays : United States

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

Am J Transplant. 2018 Feb;18(2):462-466
pubmed: 28898546
Br J Clin Pharmacol. 2015 Feb;79(2):195-207
pubmed: 24341410
JAMA. 2019 Jan 15;321(2):188-199
pubmed: 30644987
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):577-586
pubmed: 28365277
Clin Infect Dis. 2017 Jul 1;65(1):166-174
pubmed: 28520865
J Antimicrob Chemother. 2019 Jun 1;74(6):1725-1730
pubmed: 30869124
Curr Allergy Asthma Rep. 2019 Mar 22;19(5):27
pubmed: 30903298
J Antimicrob Chemother. 2016 Jun;71(6):1715-22
pubmed: 26895771
J Allergy Clin Immunol Pract. 2019 Mar;7(3):1063-1065.e5
pubmed: 30172019
J Allergy Clin Immunol. 2014 Mar;133(3):790-6
pubmed: 24188976
Arch Intern Med. 2000 Oct 9;160(18):2819-22
pubmed: 11025792
Lancet. 2019 Jan 12;393(10167):183-198
pubmed: 30558872
Transpl Infect Dis. 2018 Dec;20(6):e12968
pubmed: 30030892
J Antimicrob Chemother. 2018 Nov 1;73(11):3209-3211
pubmed: 30060208
Open Forum Infect Dis. 2018 Nov 17;5(12):ofy306
pubmed: 30547046
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2185-2191.e1
pubmed: 30928660
BMJ. 2018 Jun 27;361:k2400
pubmed: 29950489
N Engl J Med. 2003 Oct 23;349(17):1628-35
pubmed: 14573734
Med J Aust. 2018 Jun 18;208(11):469-470
pubmed: 29902399
Curr Opin Infect Dis. 2013 Dec;26(6):526-37
pubmed: 24126717
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
Antimicrob Resist Infect Control. 2015 Jun 01;4:23
pubmed: 26034582
Bone Marrow Transplant. 2009 Oct;44(8):467-70
pubmed: 19861980
Leuk Lymphoma. 2012 Jun;53(6):1169-73
pubmed: 22035415
Curr Allergy Asthma Rep. 2014 Nov;14(11):476
pubmed: 25216741
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):365-34.e1
pubmed: 25609352
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1341-1343.e1
pubmed: 30266590
J Allergy Clin Immunol Pract. 2020 Feb;8(2):757-760.e4
pubmed: 31319222
Clin Infect Dis. 2018 Jun 18;67(1):27-33
pubmed: 29346543

Auteurs

Jason A Trubiano (JA)

Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; Department of Medicine (Austin Health), University of Melbourne, Parkville, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia. Electronic address: jason.trubiano@austin.org.au.

Monica A Slavin (MA)

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.

Karin A Thursky (KA)

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Parkville, VIC, Australia.

M Lindsay Grayson (ML)

Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia; Department of Medicine (Austin Health), University of Melbourne, Parkville, VIC, Australia.

Elizabeth J Phillips (EJ)

Department of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, Tenn; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH